
Is VTRS (Viatris Inc.) Halal or Haram?
While Viatris operates in a completely permissible healthcare sector with zero interest income, its massive debt burden makes it doubtful for Muslim investors. The company's debt-to-market capitalization ratio sits at an alarming 85.1%, far exceeding the AAOIFI threshold of 33%. Consequently, despite passing the cash and interest income screens, the stock fails the overall shariah compliance test due to excessive leverage.
Price Chart (5D)
VTRS — Last 7 Days
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| 2026-06-09 | 16.13 | 16.41 | 15.93 | 16.20 | 7.8M | +0.43% |
| 2026-06-08 | 16.05 | 16.18 | 15.79 | 15.93 | 9.3M | -0.75% |
| 2026-06-05 | 15.87 | 16.19 | 15.86 | 15.88 | 9.0M | +0.06% |
| 2026-06-04 | 15.70 | 15.99 | 15.64 | 15.90 | 7.5M | +1.27% |
| 2026-06-03 | 15.68 | 15.72 | 15.50 | 15.56 | 7.0M | -0.77% |
| 2026-06-02 | 15.87 | 15.93 | 15.60 | 15.69 | 9.0M | -1.13% |
| 2026-06-01 | 16.17 | 16.17 | 15.73 | 15.81 | 12.5M | -2.23% |
Discussion
Sign in to join the discussion
Loading comments...
Shariah Screening Details for VTRS
Business Activity
Permissible
Viatris passes the business activity screen as its core operations in producing prescription brands, complex generics, and active pharmaceutical ingredients are entirely permissible under Islamic finance principles.
Debt / Market Cap
85.11%
Interest Income
0.00%
Cash & Securities
8.42%
About Viatris Inc. (VTRS)
Viatris Inc. is a global healthcare giant specializing in prescription brand drugs, complex generics, and biosimilars. The company supplies critical medications across various therapeutic areas, including oncology, immunology, and cardiovascular health, as well as active pharmaceutical ingredients (APIs) to markets worldwide.
For Muslim investors using HalalStocks.co.uk, Viatris is currently classified as Doubtful under AAOIFI standards. Although its core pharmaceutical business is entirely halal and it comfortably passes the interest income and cash screens, it critically fails the leverage test, meaning investors should avoid the stock for now.
The primary concern from an Islamic finance perspective is Viatris's excessive debt load, with a debt-to-market cap ratio of 85.1%, severely breaching the 33% limit. Fortunately, the company relies purely on its operational revenue rather than interest-bearing investments, boasting a perfect 0.00% interest income to revenue ratio.
Since the non-compliance stems entirely from its capital structure rather than its life-saving business activities, Muslim investors should closely monitor Viatris's balance sheet. If the company successfully pays down its debt or its market capitalization increases significantly, it could potentially cross back into shariah-compliant territory in the future.
CEO
Scott Andrew Smith
Employees
32,000
IPO Date
1980-03-17
Headquarters
Canonsburg, PA, US
Website
www.viatris.comVTRS Key Financial Statistics
Revenue
$14.30B
Net Income
$-3.51B
EPS (Diluted)
$-3.00
Stock Price
14.84
Beta
0.82
52-Week Range
8.19-16.47
Total Debt
$14.70B
Total Equity
$14.71B
Current Ratio
1.30
VTRS Financial Health & Profitability
Profit Margins
Revenue Growth (YoY)
-3.0%
Prior year: $14.74B
Net Debt
$13.35B
Cash: $1.35B — Debt: $14.70B
R&D Spending
$965.9M
% of Revenue
6.8%
Frequently Asked Questions About VTRS
Is VTRS (Viatris Inc.) stock halal to invest in?▾
What does Viatris Inc. do?▾
What screening criteria were used for VTRS?▾
When was VTRS last screened?▾
Disclaimer
This shariah compliance assessment for VTRS (Viatris Inc.) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-29.